)
Biomea Fusion (BMEA) investor relations material
Biomea Fusion Evercore ISI 8th Annual HealthCONx Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Business overview and scientific approach
Focused on improving healthcare for diabetics, with expanding interest in obesity treatment.
Targeting Menin protein to stimulate beta cell production and potentially cure diabetes.
Early clinical data shows sustained A1C reduction in insulin-deficient patients, even after nine months off drug.
Developed an oral GLP-1 drug to address obesity, complementing Menin-targeted therapy.
Preclinical data indicates Menin inhibition upregulates GLP-1 and its receptors, supporting the therapeutic rationale.
Clinical trial updates and patient segmentation
Two phase II studies (COVALENT-211 and 212) will focus on severe insulin-deficient and GLP-1 responder subgroups.
Patient subgroups identified using a Swedish algorithm based on A1C, BMI, and diabetes duration.
Severe insulin-deficient subgroup represents about 25% of type 2 diabetics, with higher prevalence in Asian populations.
Plans to enroll first patients in both phase II studies in Q1.
Exploring application in type 1 diabetes in collaboration with Harvard, based on promising cell replication data.
Safety, dosing, and exposure optimization
Liver enzyme elevations at higher doses were mitigated by titration; 100 mg dose cleared by FDA.
Ongoing food effect studies to refine dosing instructions and minimize exposure variability.
New dosing guidelines expected in Q1, aiming for clear, patient-friendly instructions.
Next Biomea Fusion earnings date
Next Biomea Fusion earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage